Bioxel signs paclitaxel agreement with second European generic manufacturer

By Elaine Rigoli

Tampa, Fla., Feb. 23 - Bioxel Pharma, Inc. announced that it has completed a two-year, renewable paclitaxel manufacturing and supply agreement with a leading generic manufacturer in Europe.

This marks the second commercial agreement signed by Bioxel for the sale of paclitaxel in Europe in the past four months. Paclitaxel deliveries to this new client should generate revenues of about $800,000 in 2006, according to a company news release.

"We continue to build momentum in Europe with this important agreement," said Pascal Delmas, Bioxel president and chief executive officer, in a statement.

"It meets our objective to expand in Europe and broaden our client base with generic manufacturers, and therefore clearly contribute to the diversification of our revenue streams," Delmas said. "Bioxel differentiates itself by a secure taxane supply chain, competitive quality products and outstanding customer support. Our offering is attractive to established pharmaceutical manufacturers that value Bioxel's reliable and sustainable supply solution and our strategic taxane position with both paclitaxel and docetaxel."

This agreement follows the paclitaxel order announced by Bioxel on Dec. 9, 2005. Bioxel's client is presently marketing a generic paclitaxel formulation in several E.U. countries and is obtaining approvals throughout Europe. Bioxel did not disclose the generic manufacturer or specific terms of this agreement.

Bioxel Pharma, based in Sainte-Foy, Quebec, is a biopharmaceutical company focused on developing, manufacturing and marketing taxane pharmaceutical ingredients.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.